TILT Biotherapeutics Announces Final Close of €22 Million Financing Round to Advance to Phase II Oncology Immunotherapy Trials

Read full release

Anocca secures EUR25 million from the European Investment Bank (EIB) to support clinical development of next-generation T-cell therapies for cancer

Read full release

Laevoroc Oncology Announces Publication Identifying Purine Nucleoside Phosphorylase (PNP) as Novel Metabolic Immune Checkpoint

Read full release

Partnership of BC Platforms, Euformatics and Oncompass Medicine, Selected to Deliver Standardized Oncology NGS Workflows for Seven Major European Hospitals

Read full release